Okada Purifying Therapy
Showing 1 - 25 of >10,000
International Study of Biofield Therapy
Completed
- Pain
- +3 more
- Okada Purifying Therapy
- (no location specified)
Jun 19, 2019
Drugs Mixed Ex Vivo With Sputum for Mucolytic Treatment
Recruiting
- Cystic Fibrosis
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 29, 2022
User Experience of the OSR M-1
Suspended
- Covid19
-
Winston-Salem, North CarolinaWake Forest Baptist Health
Nov 15, 2022
Therapy Animals, Dental Anxiety, Child Behavior Trial in Charleston (Therapy Dog)
Enrolling by invitation
- Therapy Animals
- +3 more
- Therapy Dog
-
Charleston, South CarolinaMedical University of South Carolina Pediatric Dental Clinic
Sep 21, 2023
Asthma, Allergic Trial (Biocide)
Not yet recruiting
- Asthma, Allergic
- Biocide
- (no location specified)
Apr 22, 2022
Intracerebral Hemorrhage Trial in Worldwide (Recombinant Activated Factor VII (rFVIIa), Placebo)
Recruiting
- Intracerebral Hemorrhage
- Recombinant Activated Factor VII (rFVIIa)
- Placebo
-
Burlingame, California
- +48 more
Jan 25, 2023
Tenofovir Alafenamide Switch Therapy in Chronic Hepatitis B
Not yet recruiting
- Patient Satisfaction
- +3 more
- tenofovir alafenamide (TAF)
- (no location specified)
Oct 15, 2022
Hyponatremia, Subarachnoid Hemorrhage, SIADH Trial in Grenoble (Urea, PLACEBO)
Recruiting
- Hyponatremia
- +2 more
- Urea
- PLACEBO
-
Grenoble, FranceUniversity Hospital Grenoble
May 17, 2022
Cardiovascular Diseases, Cardiovascular Risk Factor, Triglycerides High Trial in Canada (Icosapent Ethyl 1000 MG Oral Capsule
Recruiting
- Cardiovascular Diseases
- +3 more
- Icosapent Ethyl 1000 MG Oral Capsule [Vascepa]
-
North York, Ontario, Canada
- +3 more
Nov 7, 2022
Temporomandibular Dysfunction Trial in Lahore (Rocabado's approach, Kraus exercises)
Recruiting
- Temporomandibular Dysfunction
- Rocabado's approach
- Kraus exercises
-
Lahore, Punjab, PakistanFatima Memorial Hospital
Nov 8, 2022
Granulomatosis With Polyangiitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Paris (Rituximab,
Not yet recruiting
- Granulomatosis With Polyangiitis
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
- Rituximab
- +2 more
-
Paris, FranceHôpital de la Croix Saint Simon
Oct 10, 2022
sCLEC-2 in Stroke Study
Not yet recruiting
- Acute Ischemic Stroke
- Transient Ischemic Attack
-
Katori, Chiba, Japan
- +8 more
Oct 10, 2022
Activated PI3K-delta Syndrome, Immunodeficiency Primary Trial in Shanghai (Rapamycin)
Recruiting
- Activated PI3K-delta Syndrome
- Immunodeficiency Primary
-
Shanghai, Shanghai, China
- +1 more
Mar 21, 2022
Chronic Hepatitis B Trial in Tai'an (Metformin & Entecavir, Placebo & Entecavir)
Completed
- Chronic Hepatitis B
- Metformin & Entecavir
- Placebo & Entecavir
-
Tai'an, Shandong, ChinaThe 960th Hospital of Chinese PLA Joint Logistics Support Force
Nov 23, 2021
Testicular Proteins for Sperm Retrieval Prediction Protein1,
Recruiting
- Non-obstructive Azoospermia
- Semen analysis
-
Cairo, EgyptCairo University hospital, department of andrology
Nov 24, 2023
Non-small-cell Lung Cancer Patients Trial in Roma (Durvalumab, Olaparib tablet, Single-agent chemo)
Recruiting
- Non-small-cell Lung Cancer Patients
- Durvalumab
- +3 more
-
Roma, RM, ItalyIstituti Fisioterapici Ospitalieri- Ifo - Istituto Regina Elena
Sep 30, 2022
Optimized Strategies and Workflows for Catheter Ablation of
Not yet recruiting
- Atrial Fibrillation
- Pulmonary vein isolation plus superior vena cava isolation
- PVI, superior vena cava isolation, and linear ablation of linear ablations of the mitral isthmus, roofline and posterior wall line of the left atrium, and cavotricuspid isthmus
-
Zhengzhou, Henan, ChinaDepartment of Cardiology, Henan Provincial People's Hospital
Nov 28, 2023
Radiation-induced Diarrhoea During Curative EBRT of Prostate and
Recruiting
- Radiation-induced Diarrhoea in Prostate and Rectal Cancer
- No intervention
-
Aalborg, North Region, DenmarkAalborg University Hospital
Jan 19, 2023
T-cell Lymphoblastic Lymphoma Trial in Shanghai, Chengdu (Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine,
Not yet recruiting
- T-cell Lymphoblastic Lymphoma
- Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin
- Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide
-
Shanghai, Shanghai, China
- +1 more
Dec 27, 2022
NSCLC (NSCLC) Trial (Dacomitinib+Anlotinib, Dacomitinib)
Not yet recruiting
- Non-Small Cell Lung Cancer (NSCLC)
- (no location specified)
Feb 28, 2022
Periodontitis, Periodontal Diseases, Smoking Trial in Ankara (Non-surgical periodontal treatment)
Completed
- Periodontitis
- +3 more
- Non-surgical periodontal treatment
-
Ankara, Turkey
- +1 more
Mar 15, 2022
Schizophrenia Relapse Trial (reduction of risperidone, haloperidol, olanzapine, quetiapine, aripiprazole, paliperidone,
Completed
- Schizophrenia Relapse
- reduction of risperidone, haloperidol, olanzapine, quetiapine, aripiprazole, paliperidone, levomepromazine, perphenazine
- (no location specified)
Aug 11, 2021
Down Syndrome, Obstructive Sleep Apnea Trial in United States (Oxygen)
Not yet recruiting
- Down Syndrome
- Obstructive Sleep Apnea
-
Los Angeles, California
- +6 more
Sep 25, 2023